ORBIMED ADVISORS LLC 13D and 13G filings for VectivBio Holding AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-24 4:52 pm Sale | 2023-05-21 | 13D | VECTIVBIO HLDG AG VECT | ORBIMED ADVISORS LLC | 5,156,561 7.700% | -1,557,000 (-23.19%) | Filing |
| 2023-02-14 5:12 pm Purchase | 2022-12-31 | 13G | VECTIVBIO HLDG AG VECT | ORBIMED ADVISORS LLC | 6,713,561 10.700% | 1,810,057 (+36.91%) | Filing |
| 2022-02-11 4:51 pm Purchase | 2021-12-31 | 13G | VECTIVBIO HLDG AG VECT | ORBIMED ADVISORS LLC | 4,903,504 14.000% | 73,500 (+1.52%) | Filing |